Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Clinical trial NCT04415853 · RECRUITING

Trial details

NCT number: NCT04415853
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2021-01-21
Primary completion: 2026-08-01
Enrollment: 416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.